Study Of Effects Of Oral CREON Capsules In Adult Participants With Exocrine Pancreatic Insufficiency Not Due To Cystic Fibrosis, Chronic Pancreatitis, Pancreatectomy, Or Pancreatic Cancer

Change In Gastrointestinal (GI) Symptoms From Baseline

Change in GI symptoms is measured by AbbVie exocrine pancreatic insufficiency (EPI) symptom questionnaire. EPI symptom questionnaire is a 12-item patient-reported outcome (PRO) instrument that assesses EPI symptoms over the past 7 days.

Time frame: Week 1

Change In Stool Frequency From Baseline

Stool frequency per 24 hours will be recorded daily during the 2 confinement periods. The average stool frequency per 24 hours during confinement period 1 will be considered as baseline.

Time frame: Week 1

Change In Stool Consistency From Baseline

Stool consistency will be evaluated using the Bristol Stool Scale. The Bristol Stool chart is a medical aid designed to classify feces.

Time frame: Week 1

Change In Vitamin D From Baseline

Change from Baseline in vitamin D will be assessed through clinical laboratory testing.

Time frame: Up To Week 27

Change In Vitamin E From Baseline

Change from Baseline in vitamin E will be assessed through clinical laboratory testing.

Time frame: Up To Week 27

Change In Vitamin K From Baseline

Change from Baseline in vitamin K will be assessed through clinical laboratory testing.

Time frame: Up To Week 27

Change In Vitamin A From Baseline

Change from Baseline in vitamin A will be assessed through clinical laboratory testing.

Time frame: Up To Week 27

Change In Retinol-Binding Protein From Baseline

Change from Baseline in retinol-binding protein will be assessed through clinical laboratory testing.

Time frame: Up To Week 27

Change In Albumin From Baseline

Change from Baseline in albumin will be assessed through clinical laboratory testing.

Time frame: Up To Week 27

Change In Prealbumin From Baseline

Change from Baseline in prealbumin will be assessed through clinical laboratory testing.

Time frame: Up To Week 27

Change In Transferrin From Baseline

Change from Baseline in transferrin will be assessed through clinical laboratory testing.

Time frame: Up To Week 27

Change In Weight From Baseline

The mean change of weight from Baseline will be calculated.

Time frame: Up To Week 27

Change In Body Mass Index (BMI) From Baseline

BMI is a measure of body fat based on weight in relation to height.

Time frame: Up To Week 27

Change In Hip Circumference From Baseline

Hip circumference is measured by placing the measuring tape around the maximum circumference of the buttocks.

Time frame: Up To Week 27

Change In Waist Circumference From Baseline

Waist circumference is measured by placing a measuring tape on top of the hip bone and wrapping the tape around the waist.

Time frame: Up To Week 27

Change In Gastrointestinal Quality Of Life Index (GIQLI) From Baseline

GIQLI is a 36-item patient reported outcome (PRO) instrument used to assess GI-specific quality of life in participants with GI disorders, with response score ranging from 0 to 4 (0 being "all the time" and 4 being "never").

Time frame: Up To Week 27